Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin suggests abnormal palate development after palatal fusion

Hideto Imura, Tomohiro Yamada, Katsuaki Mishima, Kumiko Fujiwara, Harumi Kawaki, Azumi Hirata, Norio Sogawa, Takaaki Ueno, Toshio Sugahara

研究成果: ジャーナルへの寄稿記事

13 引用 (Scopus)

抄録

Mouse embryos exposed to 2,3,7,8-tetrachloridedibenzo-p-dioxin (TCDD) develop cleft palates and hydronephrosis. Cleft palates occur after TCDD exposure due to contact and/or fusion failure. We investigated whether cleft palate can be induced by dissociation of the palatine process after fusion. Pregnant mice on gestational day (GD) 12 were randomly divided into two groups: one group was administered through gastric tubes one dose of olive oil (control group) and the other group was administered one dose of TCDD diluted with olive oil, both at a dose of 40 μg/kg body weight. Embryos were removed by cesarean section from pregnant mice during the palatal formation stage (GD 13-18) and the palatal form was observed using a stereoscopic microscope. In TCDD-exposed embryos, palatal fusion was observed on GD 14, 15 and 16 and the incidence of cleft palate was 100% on GD 18. Fusion rates were 17.5 ± 15.2% and 12.4 ± 11.8% on GD 15 and 16, respectively. Some palates from the TCDD-exposed mouse embryos showed clearly developed cleft palate after fusion of the lateral palatine processes during palatal formation. A mass of cells, which were chiefly epithelial in the fused palates was observed in the TCDD-exposed mouse embryos. A decrease in E-cadherin expression was observed in this mass of cells, indicating its involvement in the development of cleft palate.

元の言語英語
ページ(範囲)77-84
ページ数8
ジャーナルCongenital Anomalies
50
発行部数2
DOI
出版物ステータス出版済み - 1 1 2010

Fingerprint

Palate
Cleft Palate
Embryonic Structures
Hydronephrosis
Cadherins
Cesarean Section
1,4-dioxin
Polychlorinated Dibenzodioxins
Stomach
Body Weight
Control Groups
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin suggests abnormal palate development after palatal fusion. / Imura, Hideto; Yamada, Tomohiro; Mishima, Katsuaki; Fujiwara, Kumiko; Kawaki, Harumi; Hirata, Azumi; Sogawa, Norio; Ueno, Takaaki; Sugahara, Toshio.

:: Congenital Anomalies, 巻 50, 番号 2, 01.01.2010, p. 77-84.

研究成果: ジャーナルへの寄稿記事

Imura, H, Yamada, T, Mishima, K, Fujiwara, K, Kawaki, H, Hirata, A, Sogawa, N, Ueno, T & Sugahara, T 2010, 'Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin suggests abnormal palate development after palatal fusion', Congenital Anomalies, 巻. 50, 番号 2, pp. 77-84. https://doi.org/10.1111/j.1741-4520.2010.00271.x
Imura, Hideto ; Yamada, Tomohiro ; Mishima, Katsuaki ; Fujiwara, Kumiko ; Kawaki, Harumi ; Hirata, Azumi ; Sogawa, Norio ; Ueno, Takaaki ; Sugahara, Toshio. / Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin suggests abnormal palate development after palatal fusion. :: Congenital Anomalies. 2010 ; 巻 50, 番号 2. pp. 77-84.
@article{55599930df77437bac5c22f952e28ea1,
title = "Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin suggests abnormal palate development after palatal fusion",
abstract = "Mouse embryos exposed to 2,3,7,8-tetrachloridedibenzo-p-dioxin (TCDD) develop cleft palates and hydronephrosis. Cleft palates occur after TCDD exposure due to contact and/or fusion failure. We investigated whether cleft palate can be induced by dissociation of the palatine process after fusion. Pregnant mice on gestational day (GD) 12 were randomly divided into two groups: one group was administered through gastric tubes one dose of olive oil (control group) and the other group was administered one dose of TCDD diluted with olive oil, both at a dose of 40 μg/kg body weight. Embryos were removed by cesarean section from pregnant mice during the palatal formation stage (GD 13-18) and the palatal form was observed using a stereoscopic microscope. In TCDD-exposed embryos, palatal fusion was observed on GD 14, 15 and 16 and the incidence of cleft palate was 100{\%} on GD 18. Fusion rates were 17.5 ± 15.2{\%} and 12.4 ± 11.8{\%} on GD 15 and 16, respectively. Some palates from the TCDD-exposed mouse embryos showed clearly developed cleft palate after fusion of the lateral palatine processes during palatal formation. A mass of cells, which were chiefly epithelial in the fused palates was observed in the TCDD-exposed mouse embryos. A decrease in E-cadherin expression was observed in this mass of cells, indicating its involvement in the development of cleft palate.",
author = "Hideto Imura and Tomohiro Yamada and Katsuaki Mishima and Kumiko Fujiwara and Harumi Kawaki and Azumi Hirata and Norio Sogawa and Takaaki Ueno and Toshio Sugahara",
year = "2010",
month = "1",
day = "1",
doi = "10.1111/j.1741-4520.2010.00271.x",
language = "English",
volume = "50",
pages = "77--84",
journal = "Congenital Anomalies",
issn = "0914-3505",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin suggests abnormal palate development after palatal fusion

AU - Imura, Hideto

AU - Yamada, Tomohiro

AU - Mishima, Katsuaki

AU - Fujiwara, Kumiko

AU - Kawaki, Harumi

AU - Hirata, Azumi

AU - Sogawa, Norio

AU - Ueno, Takaaki

AU - Sugahara, Toshio

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Mouse embryos exposed to 2,3,7,8-tetrachloridedibenzo-p-dioxin (TCDD) develop cleft palates and hydronephrosis. Cleft palates occur after TCDD exposure due to contact and/or fusion failure. We investigated whether cleft palate can be induced by dissociation of the palatine process after fusion. Pregnant mice on gestational day (GD) 12 were randomly divided into two groups: one group was administered through gastric tubes one dose of olive oil (control group) and the other group was administered one dose of TCDD diluted with olive oil, both at a dose of 40 μg/kg body weight. Embryos were removed by cesarean section from pregnant mice during the palatal formation stage (GD 13-18) and the palatal form was observed using a stereoscopic microscope. In TCDD-exposed embryos, palatal fusion was observed on GD 14, 15 and 16 and the incidence of cleft palate was 100% on GD 18. Fusion rates were 17.5 ± 15.2% and 12.4 ± 11.8% on GD 15 and 16, respectively. Some palates from the TCDD-exposed mouse embryos showed clearly developed cleft palate after fusion of the lateral palatine processes during palatal formation. A mass of cells, which were chiefly epithelial in the fused palates was observed in the TCDD-exposed mouse embryos. A decrease in E-cadherin expression was observed in this mass of cells, indicating its involvement in the development of cleft palate.

AB - Mouse embryos exposed to 2,3,7,8-tetrachloridedibenzo-p-dioxin (TCDD) develop cleft palates and hydronephrosis. Cleft palates occur after TCDD exposure due to contact and/or fusion failure. We investigated whether cleft palate can be induced by dissociation of the palatine process after fusion. Pregnant mice on gestational day (GD) 12 were randomly divided into two groups: one group was administered through gastric tubes one dose of olive oil (control group) and the other group was administered one dose of TCDD diluted with olive oil, both at a dose of 40 μg/kg body weight. Embryos were removed by cesarean section from pregnant mice during the palatal formation stage (GD 13-18) and the palatal form was observed using a stereoscopic microscope. In TCDD-exposed embryos, palatal fusion was observed on GD 14, 15 and 16 and the incidence of cleft palate was 100% on GD 18. Fusion rates were 17.5 ± 15.2% and 12.4 ± 11.8% on GD 15 and 16, respectively. Some palates from the TCDD-exposed mouse embryos showed clearly developed cleft palate after fusion of the lateral palatine processes during palatal formation. A mass of cells, which were chiefly epithelial in the fused palates was observed in the TCDD-exposed mouse embryos. A decrease in E-cadherin expression was observed in this mass of cells, indicating its involvement in the development of cleft palate.

UR - http://www.scopus.com/inward/record.url?scp=77952565797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952565797&partnerID=8YFLogxK

U2 - 10.1111/j.1741-4520.2010.00271.x

DO - 10.1111/j.1741-4520.2010.00271.x

M3 - Article

C2 - 20156238

AN - SCOPUS:77952565797

VL - 50

SP - 77

EP - 84

JO - Congenital Anomalies

JF - Congenital Anomalies

SN - 0914-3505

IS - 2

ER -